Getinge AB (publ) (GNGBY) Stock Price, News & Analysis

Company Overview

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Key Stats

• Today's Range: $19.32 to $19.45
• 50-Day Range: $17.99 to $22.24
• 52-Week Range: $14.84 to $22.85
• Volume: 13,641 shs
• Average Volume: 29,227 shs
• Market Capitalization: $5.28 billion
• P/E Ratio: 33.98
• Dividend Yield: 1.45%
• Price Target: N/A
• Consensus Rating: N/A

GNGBY Stock Analysis - Frequently Asked Questions

How have GNGBY shares performed this year?

Getinge AB (publ)'s stock was trading at $16.3850 on January 1st, 2025. Since then, GNGBY stock has increased by 18.2% and is now trading at $19.37.
View the best growth stocks for 2025 here.

How were Getinge AB (publ)'s earnings last quarter?

Getinge AB (publ) (OTCMKTS:GNGBY) released its quarterly earnings data on Tuesday, April, 22nd. The company reported $0.20 EPS for the quarter. The company had revenue of $779.56 million for the quarter. Getinge AB (publ) had a net margin of 4.71% and a trailing twelve-month return on equity of 9.84%.

How do I buy shares of Getinge AB (publ)?

Shares of GNGBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 4/22/2025
• Record date for 5/14 Dividend: 4/24/2025
• Ex-Dividend for 5/14 Dividend: 4/24/2025
• Dividend Payable: 5/14/2025
• Today: 5/27/2025
• Next Earnings (Estimated): 7/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:GNGBY
• CIK: N/A
• Web: www.getinge.com
• Phone: (610) 335-0000
• Fax: 46-1-033-556-40
• Employees: 11,386
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.51
• Trailing P/E Ratio: 33.98
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $154.96 million
• Net Margins: 4.71%
• Pretax Margin: 6.57%
• Return on Equity: 9.84%
• Return on Assets: 5.36%

Debt

• Debt-to-Equity Ratio: 0.06
• Current Ratio: 0.78
• Quick Ratio: 0.50

Sales & Book Value

• Annual Sales: $3.29 billion
• Price / Sales: 1.60
• Cash Flow: $1.52 per share
• Price / Cash Flow: 12.72
• Book Value: $10.53 per share
• Price / Book: 1.84

Miscellaneous

• Outstanding Shares: 272,370,000
• Free Float: N/A
• Market Cap: $5.28 billion
• Optionable: Not Optionable
• Beta: 1.10